课题基金 / 基金详情

Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual

Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual
研究肺部微生物组改变在 HIV 感染者 COPD 中促进 Th17 介导的气道炎症的作用
批准号:
10872354
负责人:
Alex Kayongo
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2025-06-30

项目摘要

项目成果

Alex Kayongo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Chronic Obstructive Pulmonary Disease (COPD) is increasing in prevalence among people living with HIV (PLWH) as the widespread use of antiretroviral therapy (ART) has increased longevity in this population. With the highest density of PLWH, Sub-Saharan Africa has experienced dramatic increases in COPD-related morbidity and mortality. Despite viral suppression, it’s not fully known what drives accelerated lung function decline in this population. Amidst intense exposure to environmental insults, the airways have developed robust protective mechanisms which preserve the airway microenvironment, with highly specialized lung-resident innate and adaptive immune cells fighting off pathogens. However, these protective mechanisms deteriorate with age, resulting in a progressive decline in lung function and COPD development. This decline is worse in the setting of chronic HIV infection. Despite a lack of conclusive evidence, persistent airway immune activation among PLWH possibly drives airway immunosenescence, inflammaging, and progressive lung function decline. It is probable that in the setting of chronic HIV, contraction of the T-cell immune repertoire (immune diversity) increases susceptibility to infections, which drives chronic inflammation, immune exhaustion, and senescence. In this supplementary application, we aim to investigate the effect of HIV on distal airway immunosenescence and inflammaging among individuals with COPD. We hypothesize that: (1) chronic HIV infection accelerates age-dependent contraction of airway T cell receptor diversity; (2) and this reduced diversity is associated with airway inflammation and poor lung function (low FEV1 and FVC). We will use broncho-alveolar lavage samples from our currently running parent R21 study to; (1) determine the effect of chronic HIV on airway TCR diversity and (2) correlate airway TCR diversity indices with levels of inflammaging cytokines in BAL supernatant. This preliminary data will provide a basis to investigate airway inflammaging among PLWH, supplementing our parent R21 objectives of investigating the association between lung microbiome and immune profile in the distal airways of HIV-infected individuals with COPD in a viremically controlled Ugandan HIV cohort.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual
海外基金